Cargando…

Novel Molecular Markers for Breast Cancer

The use of molecular biomarkers assures that breast cancer (BC) patients receive optimal treatment. Established biomarkers, such as estrogen receptor, progesterone receptor, HER2, and Ki67, have been playing significant roles in the subcategorization of BC to predict the prognosis and decide the spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kazushi, Fry, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790586/ https://www.ncbi.nlm.nih.gov/pubmed/26997872 http://dx.doi.org/10.4137/BIC.S38394

Ejemplares similares

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
por: Taneja, Pankaj, et al.
Publicado: (2010)

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer
por: Inoue, Kazushi, et al.
Publicado: (2013)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells
por: Hendrix, Mary JC, et al.
Publicado: (2000)

Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
por: Taneja, Pankaj, et al.
Publicado: (2011)

The Promise of Novel Molecular Markers in Bladder Cancer
por: Miremami, Jahan, et al.
Publicado: (2014)

Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53
por: Fry, Elizabeth A., et al.
Publicado: (2020)

Molecular Markers for Breast Cancer: Prediction on Tumor Behavior
por: Banin Hirata, Bruna Karina, et al.
Publicado: (2014)

The Important Molecular Markers on Chromosome 17 and Their Clinical Impact in Breast Cancer
por: Zhang, Wei, et al.
Publicado: (2011)

Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
por: Fry, Elizabeth A., et al.
Publicado: (2013)

Novel applications of molecular imaging to guide breast cancer therapy
por: Edmonds, Christine E., et al.
Publicado: (2022)

Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
por: Rouzier, Roman, et al.
Publicado: (2013)

Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast
por: Nasir, Aejaz, et al.
Publicado: (2011)

Identification of early molecular markers for breast cancer
por: Kretschmer, Céline, et al.
Publicado: (2011)

Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
por: Birkó, Zsuzsanna, et al.
Publicado: (2020)

Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer
por: Hobbs, Evthokia A., et al.
Publicado: (2022)

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers
por: Wu, Hua-Hsi, et al.
Publicado: (2014)

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update
por: Mohanty, Swati Sucharita, et al.
Publicado: (2020)

Important molecular genetic markers of colorectal cancer
por: Kudryavtseva, Anna V., et al.
Publicado: (2016)

The In Vivo Selection Method in Breast Cancer Metastasis
por: Nakayama, Jun, et al.
Publicado: (2021)

IL-8 is a novel marker for breast cancer
por: Chavey, C, et al.
Publicado: (2005)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

Identification of Novel Genetic Markers of Breast Cancer Survival
por: Guo, Qi, et al.
Publicado: (2015)

Molecular Markers in Sex Differences in Cancer
por: Shin, Ji Yoon, et al.
Publicado: (2019)

Markers for the identification of late breast cancer recurrence
por: Sestak, Ivana, et al.
Publicado: (2015)

Appraisal of progenitor markers in the context of molecular classification of breast cancers
por: Haviv, Izhak
Publicado: (2011)

Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?
por: Fry, Michael John
Publicado: (2001)

Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma
por: Zagouri, Flora, et al.
Publicado: (2007)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Actionable pharmacogenetic markers for prediction and prognosis in breast cancer
por: Sacco, Keith, et al.
Publicado: (2015)

Classic and New Markers in Diagnostics and Classification of Breast Cancer
por: Beňačka, Roman, et al.
Publicado: (2022)

Fecal Molecular Markers for Colorectal Cancer Screening
por: Kanthan, Rani, et al.
Publicado: (2012)

Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants
por: Kleer, Celina G, et al.
Publicado: (2000)

Molecular analyses of human breast cancer metastasis: genetic markers of progression
por: Driouch, K, et al.
Publicado: (2000)

Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers
por: Mota, André de Lima, et al.
Publicado: (2017)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Colorectal Cancer Screening Methods and Molecular Markers for Early Detection
por: Wu, Ziwei, et al.
Publicado: (2020)

Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
por: Roy, David M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s4vbrjp461kkflhh1d9v45ns86